Qube Research & Technologies (QRT)
SCNI

Qube Research & Technologies (QRT)’s Scinai Immunotherapeutics SCNI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SCNI Stock Details SCNI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Hold
0
– -$4 – 4606
2024
Q1 		– Hold
0
– – – 4341
2023
Q4 		– Hold
0
– – – 4220
2023
Q3 		– Hold
0
– – – 3962

Other funds holding SCNI

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return
MSG
Main Street Group Glen Allen, Virginia $429M AUM 34.03% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM